Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality

被引:3
|
作者
Li, Xun [1 ]
Yan, Haipeng [2 ]
Luo, Ting [1 ]
Xiao, Zhenghui [2 ]
Gong, Ling [2 ]
Huang, Jiaotian [2 ]
Zhang, Xinping [2 ]
Zheng, Mincui [3 ]
Yao, Zhenya [2 ]
Zang, Ping [2 ]
Zhu, Desheng [2 ]
Lu, Xiulan [2 ]
机构
[1] Hunan Childrens Hosp, Pediat Res Inst Hunan Prov, Dept Pediat Intens Care Unit PICU, Changsha, Peoples R China
[2] Hunan Childrens Hosp, Dept Pediat Intens Care Unit PICU, Changsha, Peoples R China
[3] Hunan Childrens Hosp, Dept Pediat Hematol, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
Child; Fibrinogen; Multiple organ dysfunction syndrome; Hemophagocytic lymphohistiocytosis; Triglyceride; TRIGLYCERIDE-RICH LIPOPROTEINS; PROGNOSTIC-FACTORS; EARLY DEATH; GUIDELINES; SEPSIS; AGENTS; HLH;
D O I
10.1186/s13023-022-02315-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disorder. How to stratify high risk patients is one of the current challenges for the treatment of HLH. HLH patients usually fulfill multiple but not all eight diagnostic criteria. Different combinations of the fulfilled criteria may naturally cluster into previously undescribed subsets or phenotypes that may have different pathophysiology and demonstrate different risks for a poor outcome. The objectives of this study were to identify HLH subgroups according to the fulfillment of diagnostic criteria and evaluate the risk of multiple organ dysfunction syndrome (MODS) and 30-day mortality for subgroups. We retrospectively collect medical records of patients with discharge diagnosis of HLH between June 2015 and October 2018 from a tertiary children's hospital in China. Latent class analysis was used to identify class defining variables from HLH diagnostic items, and subgroups were defined according to different combinations of the class defining variables. Results Triglyceride and fibrinogen were identified as the class defining variables. When evaluated in combinations, patients with hypertriglyceridemia and normal fibrinogen levels during hospitalization had the lowest risks for MODS (27.8%, OR = 1) and 30-day mortality (18.8%, OR = 1), and patients with normal triglyceride and hypofibrinogenemia had the highest risks for MODS (86.2%, OR = 16.24, P = 0.0002) and 30-day mortality (57.1%, OR = 5.78, P = 0.0187). The fulfillment status of hypertriglyceridemia and hypofibrinogenemia within 72 h of hospital admission was also associated with the risk of adverse outcomes. Conclusions The fulfillment status of hypertriglyceridemia and hypofibrinogenemia were associated with the risks of MODS and 30-day mortality among pediatric HLH patients. Further studies are needed to validate this association and investigate its clinical utility in the severity evaluation for HLH.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality
    Xun Li
    Haipeng Yan
    Ting Luo
    Zhenghui Xiao
    Ling Gong
    Jiaotian Huang
    Xinping Zhang
    Mincui Zheng
    Zhenya Yao
    Ping Zang
    Desheng Zhu
    Xiulan Lu
    [J]. Orphanet Journal of Rare Diseases, 17
  • [2] An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: Hemophagocytic lymphohistiocytosis
    Karapinar, Buelent
    Yilmaz, Deniz
    Balkan, Can
    Akin, Mehmet
    Ay, Yilmaz
    Kvakli, Kaan
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2009, 10 (03) : 285 - 290
  • [3] Case report: Hemophagocytic lymphohistiocytosis complicated by multiple organ dysfunction syndrome following aseptic encephalitis
    Chen, Quan-Ting
    Chen, Ming-Hua
    Lin, Yu-Kai
    Yeh, Ren-Hua
    Lu, Chun-Chi
    Hsiao, Po-Jen
    Sung, Yueh-Feng
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [4] Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome
    Gauvin, F
    Toledano, B
    Champagne, J
    Lacroix, J
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (09) : 3341 - 3345
  • [5] Hydrops fetalis and early neonatal multiple organ failure in familial hemophagocytic lymphohistiocytosis
    Vermeulen, Marijn J.
    de Haas, Valerie
    Mulder, Margot F.
    Flohil, Claudie
    Fetter, Willem P. F.
    van de Kamp, Jiddeke M.
    [J]. EUROPEAN JOURNAL OF MEDICAL GENETICS, 2009, 52 (06) : 417 - 420
  • [6] Human monocytic ehrlichiosis complicated by hemophagocytic lymphohistiocytosis and multi-organ dysfunction syndrome
    Kaplan, Rachel M.
    Swat, Stanley A.
    Singer, Benjamin D.
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (03) : 327 - 328
  • [7] Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demet Demirkol
    Dincer Yildizdas
    Benan Bayrakci
    Bulent Karapinar
    Tanil Kendirli
    Tolga F Koroglu
    Oguz Dursun
    Nilgün Erkek
    Hakan Gedik
    Agop Citak
    Selman Kesici
    Metin Karabocuoglu
    Joseph A Carcillo
    [J]. Critical Care, 16
  • [8] Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol, Demet
    Yildizdas, Dincer
    Bayrakci, Benan
    Karapinar, Bulent
    Kendirli, Tanil
    Koroglu, Tolga F.
    Dursun, Oguz
    Erkek, Nilgun
    Gedik, Hakan
    Citak, Agop
    Kesici, Selman
    Karabocuoglu, Metin
    Carcillo, Joseph A.
    [J]. CRITICAL CARE, 2012, 16 (02):
  • [9] Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab
    Hahn, Timothy J.
    Mckeone, Daniel J.
    Beal, James W.
    Ericson, Jessica E.
    Halstead, E. Scott
    [J]. FRONTIERS IN PEDIATRICS, 2024, 11
  • [10] How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis
    Carcillo, Joseph A.
    Simon, Dennis W.
    Podd, Bradley S.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2015, 16 (06) : 598 - 600